Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children

被引:0
|
作者
Erazmus, Michal [1 ]
Ruminska, Malgorzata [1 ]
Witkowska-Sedek, Ewelina [1 ]
Kucharska, Anna M. [1 ]
Stelmaszczyk-Emmel, Anna [2 ]
Majcher, Anna [1 ]
Pyrzak, Beata [1 ]
机构
[1] Med Univ Warsaw, Dept Paediat & Endocrinol, Warsaw, Poland
[2] Med Univ Warsaw, Dept Lab Diagnost & Clin Immunol Dev Age, Warsaw, Poland
来源
关键词
sRANKL; OPG; sRANKL ratio; cardiovascular risk factors; obesity; children; LOW SERUM-LEVELS; INSULIN-RESISTANCE; RANK LIGAND; URIC-ACID; VASCULAR CALCIFICATION; METABOLIC SYNDROME; RISK-FACTORS; B LIGAND; OSTEOPROTEGERIN; ATHEROSCLEROSIS;
D O I
10.3389/fendo.2022.963467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionChildhood obesity contributes to the development of cardiovascular diseases. The molecular pathway - receptor activator of nuclear factor-kappa beta ligand (RANKL), its receptor RANK and osteoprotegerin (OPG) - takes part not only in bone metabolism but is also involved in the atherosclerosis process. RANKL stimulates osteogenic differentiation and calcification of vascular smooth cells. The associations between the OPG-sRANKL system and various cardiovascular risk factors were displayed. We aimed to evaluate the relationships between serum sRANKL (soluble RANKL) levels and the OPG/sRANKL ratio with cardiometabolic risk factors in overweight and obese children. Material and methodsThe study included 70 children with overweight and obesity (mean age 13.0 +/- 2.8) and 35 age-matched normal weight, healthy peers as a control group. In all patients, anthropometric measurements and laboratory tests were performed. Additionally, an oral glucose tolerance test (OGTT) was made only in overweight and obese children. Atherogenic and insulin resistance indices were calculated. ResultsOverweight and obese children had lower sRANKL levels compared to the control group (median 276.95 vs 325.90, p=0.011), and consequently a higher OPG/sRANKL ratio (0.02 vs 0.01, p = 0.013). The studied children in the lowest quartile of sRANKL levels had higher body weight, Body Mass Index, waist circumference and increased glucose and insulin levels 60 minutes after OGTT and higher uric acid values compared to children in the highest quartile. In multivariable linear regression analysis sRANKL negatively correlated only with uric acid (beta = - 0.508, p = 0.041). No association was found for the OPG/sRANKL ratio. ConclusionExcess fat mass seems to alter the OPG/RANKL ratio mainly by reducing serum sRANKL levels. The correlation between sRANKL and uric acid may suggest a contribution of the OPG-sRANKL system in the cardiometabolic process, but that observation should be confirmed in future studies.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-κB ligand in girls with anorexia nervosa
    Ostrowska, Zofia
    Ziora, Katarzyna
    Oswiecimska, Joanna
    Swietochowska, Elzbieta
    Marek, Bogdan
    Kajdaniuk, Dariusz
    Strzelczyk, Joanna
    Golabek, Karolina
    Wolkowska-Pokrywa, Kinga
    Kos-Kudla, Beata
    ENDOKRYNOLOGIA POLSKA, 2016, 67 (05) : 493 - 500
  • [32] Elevated soluble receptor activator of nuclear factor-κB ligand and reduced bone mineral density in patients with adolescent idiopathic scoliosis
    Suh, Kuen Tak
    Lee, Sang-Sup
    Hwang, Sang Hyun
    Kim, Seong-Jang
    Lee, Jung Sub
    EUROPEAN SPINE JOURNAL, 2007, 16 (10) : 1563 - 1569
  • [33] Free soluble receptor activator of nuclear factor-κb ligand in gingival crevicular fluid correlates with distinct pathogens in periodontitis patients
    Sakellari, Dimitra
    Menti, Sofia
    Konstantinidis, Antonis
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2008, 35 (11) : 938 - 943
  • [34] Cathepsin g enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-κB ligand
    Wilson, Thomas J.
    Nannuru, Kalyan C.
    Futakuchi, Mitsuru
    Sadanandam, Anguraj
    Singh, Rakesh K.
    CANCER RESEARCH, 2008, 68 (14) : 5803 - 5811
  • [35] Elevated soluble receptor activator of nuclear factor-κB ligand and reduced bone mineral density in patients with adolescent idiopathic scoliosis
    Kuen Tak Suh
    Sang-Sup Lee
    Sang Hyun Hwang
    Seong-Jang Kim
    Jung Sub Lee
    European Spine Journal, 2007, 16 : 1563 - 1569
  • [37] Osteoprotegerin, receptor activator of nuclear factor κB and receptor activator of nuclear factor κB ligand and bone mineralization in children with inflammatory bowel diseases
    Jankowska, Agnieszka
    Korzon-Burakowska, Anna
    Kaminska, Barbara
    PRZEGLAD GASTROENTEROLOGICZNY, 2011, 6 (04): : 213 - 217
  • [38] Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblasts
    Deyama, Y
    Kikuiri, T
    Ohnishi, G
    Feng, YG
    Takeyama, S
    Hatta, M
    Yoshimura, Y
    Suzuki, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (02) : 240 - 246
  • [39] The osteoprotegerin/receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand system in cartilage
    Komuro, H
    Olee, T
    Kühn, K
    Quach, J
    Brinson, DC
    Shikhman, A
    Valbracht, J
    Creighton-Achermann, L
    Lotz, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2768 - 2776
  • [40] Predicting the Efficacy of Novel Synthetic Compounds in the Treatment of Osteosarcoma via Anti-Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) Targets
    Zhang, Wenhua
    Xu, Siping
    Liu, Peng
    Li, Xusheng
    Yu, Xinyuan
    Kang, Bing
    MEDICINAL CHEMISTRY, 2024, 20 (07) : 733 - 740